Curriculum Vitae

A. Composition:

Name: Ahmed Fawzy El-Yazbi.

Date of Birth: June 2nd, 1979.

Nationality: Egyptian/Canadian

Higher Education:

2004-2007 Department of Pharmacology, University of Alberta. 1996-2001 Faculty of Pharmacy, Alexandria University.

Qualifications:

- BPSc Distinction Honours, 2001, Alexandria, Egypt. Graduated as Top of the 2001 class, cumulative score 96.72% - PhD in Pharmacology, 2008, University of Alberta, Edmonton, Alberta, Cumulative GPA: 4.0 (A+) - Completed the University Instructional Skills Program at the University of Alberta, 2007 - Canadian Board certified clinical pharmacist, November 2009 - Registered Clinical Pharmacist, Alberta College of Pharmacists, November 2010 - Certified Injection Pharmacist, Alberta College of Pharmacists, May 2012 - Board Certified Pharmacotherapy Specialist, Board of Pharmacy Specialties, Washington DC, USA, January 2013

Previous employment and appointments held:

2001-2002 Medical Sales Representative, Novartis Pharmaceuticals, Alexandria, Egypt

2001-2004 Research and teaching assistant, Dept of Pharmacology, Alexandria University, Egypt

2002-2003 Community Pharmacist, El-Emary

Charity Hospital, Alexandria, Egypt 2003-2004 Pharmacy Manager, El-Emary Charity

Hospital, Alexandria, Egypt 2004-2007 Research Assistant, Dept of

Pharmacology, University of Alberta 2008-2011 Post-doctoral fellow, Smooth Muscle

Research Group, Faculty of Medicine, University of Calgary, Alberta, Canada

2010-2011 Staff Pharmacist, Shoppers Drug Mart

#384, 307, and relief pharmacist at Shoppers Drug Mart #314, 305

2011-2013 Associate/Owner of Shoppers Drug Mart #2347 and 2337, Outpatient Pharmacies at the Peter Lougheed Centre and the Foothills Medical Centre, Calgary, Alberta 2013-2015 Executive Director of the Quality Assurance Unit, Faculty of Pharmacy, Alexandria University

Present Appointment(s):

Associate-Professor of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt Aug 2015 – Present Sep 2013 – Aug 2015 (Assistant Professor) Jan 2009 – Aug 2013 (On leave) Visiting professor of Pharmacy Practice, Beirut Arab University, Beirut, Lebanon

Co-Founder and Career Development Advisor, ClinMedEx Inc., Calgary, Alberta, Canada (More Information available at www.clinmedex.ca Oct 2010 - present Academic and training consultant, Stellar, Cairo, Egypt Sep 2013 - present

B. Teaching: Very extensive teaching profile including skill development and

evaluation. I taught at Faculties of Pharmacy, Medicine and

Dentistry, and Medicine in Alexandria University, University of

Alberta, University of Calgary, and Beirut Arab University. Details

are available in a teaching dossier upon request

C. Academic and Research Standing: h-index (according to Google Scholar): 14.

Full-length peer reviewed papers:

Published:

1. Omar AG, Sharabi FM, Daabees TT, El-Mallah AI, and El-Yazbi A. Comparative functional antagonistic potencies of tamsulosin and terazosin at α1-adrenoceptors in vitro. J Egypt Soc Pharm Exp Ther 26: 569-587, 2005.

2. El-Yazbi AF, Cho WJ, Boddy G, and Daniel EE. Caveolin-1 gene knock out impairs nitrergic function in mouse small intestine. Br J Pharmacol 145: 1017-1026, 2005.

3. El-Yazbi AF, Cho WJ, Boddy G, Schulz R, and Daniel EE. Impact of Caveolin-1 knockout on NANC relaxation in circular muscle of the mouse small intestine compared with longitudinal muscle. Am J Physiol 290: G394-G403, 2006.

4. El-Yazbi AF, Schulz R, Cho WJ, and Daniel EE. Caveolin-1 knockout alters β-adrenoceptors function in mouse small intestine. Am J Physiol 291: G1020-G1030, 2006.

5. Daniel EE, El-Yazbi A, and Cho WJ. Caveolae and Calcium

Handling, a Review and a Hypothesis J Cell Mol Med 10: 529-544, 2006.

6. El-Yazbi AF, Schulz R, and Daniel EE. Different inhibitory control of circular and longitudinal smooth muscle layers of mouse small intestine. Auton Neurosci 131: 36-44, 2007.

7. Daniel EE, El-Yazbi AF, Mannarino M, Galante G, Boddy G, Livergant J, and Oskouei TE. Do gap junctions play a role in nerve transmission as well as pacing in mouse intestine? Am J Physiol 292: G734-G745, 2007.

8. Chow AK, Cena J, El-Yazbi AF, Crawford BD, Holt A, Cho WJ, Daniel EE, and Schulz, R. Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. J Mol Cell Cardiol 42: 896-901, 2007.

9. El-Yazbi AF, Cho WJ, Cena J, Schulz R, and Daniel EE. Smooth muscle nitric oxide synthase, colocalized with caveolin-1, modulates depolarization-induced contraction in mouse small intestine. J Cell Mol Med 12: 1404-1415, 2008.

10. El-Yazbi AF, Cho WJ, Schulz R, and Daniel EE. Calcium

extrusion by plasma membrane calcium pump is impaired in caveolin-1 knockout in mouse small intestine. Eur J Pharmacol 591: 80-87, 2008.

11. Sommer B, Montaño LM, Carbajal V, Flores-Soto E, Ortega A,

Ramirez-Osiguera R, Irles C, El-Yazbi AF, Cho WJ, and Daniel EE. Extraction of membrane cholesterol disrupts caveolae and impairs serotonergic (5-HT2A) and histaminergic (H1) responses in bovine airway smooth muscle: role of Rho-kinase. Can J Physiol Pharmacol 87: 180-195, 2009.

12. Daniel EE, Eteraf T, Sommer B, Cho WJ, and El-Yazbi AF.

The role of Caveolae and caveolin-1 in calcium handling in pacing and contraction in mouse intestine. J Cell Mol Med 13: 352-364, 2009.

13. Johnson RP, El-Yazbi AF, Takeya K, Walsh EJ, Walsh MP,

and Cole WC. Ca2+sensitization via phosphorylation of myosin

phosphatise targeting subunit at threonine-855 by Rho kinase contributes to the arterial myogenic response. J Physiol 587: 2537-2553, 2009.

14. Johnson RP, El-Yazbi AF, Hughes MF, Schriemer DC, Walsh

EJ, Walsh MP, and Cole WC. Identification and Functional Characterization of Protein Kinase A-catalyzed Phosphorylation of Potassium Channel Kv1.2 at Serine 449. J Biol Chem 284: 16562-16574, 2009.

15. El-Yazbi AF, Johnson RP, Walsh EJ, Takeya K, Walsh MP,

and Cole WC. Pressure-dependent contribution of Rho kinase-mediated calcium sensitization in serotonin-evoked vasoconstriction of rat cerebral arteries. J Physiol 588: 1747-1762,2010.

16. Mufti R, Brett SE, Tran CHT, Radwan R, Anfinoginova Y, El-

Yazbi AF, Cole WC, Jones P, Chen SR, and Welsh DG. Intravascular pressure initiates cerebral arterial constriction by inducing voltage-independent Ca2+ waves. J Physiol 588: 3983-4005, 2010.

17. Zhong XZ, Abd-Elrahman KS, Liao CH, El-Yazbi AF, Walsh

EJ, Walsh MP, Cole WC. Stromatoxin-sensitive, heteromultimeric Kv2.1/Kv9.3 channels contribute to myogenic control of cerebral arterial diameter. J Physiol 588: 4519-4537, 2010.

18. Moreno-Dominguez A, Collinas O, El-Yazbi AF. Walsh E, Hill

MA, Walsh MP, Cole WC. Calcium Sensitization Due to Myosin Light Chain Phosphatase Inhibition and Cytoskeletal Reorganization in The Myogenic Response of Skeletal Muscle Resistance Arteries. J Physiol 591: 1235-1250, 2013.

19. Moreno-Dominguez A, El-Yazbi AF, Zhu HL, Colinas O,

Zhong XZ, Walsh EJ, Cole DM, Kargacin GJ, Walsh MP, Cole WC. Cytoskeletal reorganization evoked by Rho—associated kinase- and protein kinase C-catalyzed phosphorylation of cofillin and heat shock protein 27, respectively, contributes to myogenic constriction of rat cerebral arteries. J Biol Chem 289(30):20939-20952, 2014.

20. El-Yazbi AF, Abd El-Rahman KS, Moreno-Dominguez A. PKC-

mediated cerebral vasoconstriction: role of myosin light chain

phosphorylation versus actin cytoskeleton reorganization, Biochem Pharmacol 95:263-278, 2015.

21. El-Haddad G, ElAmrawy F, El-Yazbi AF, Eshra A, Nounou MI.

Male enhancement Nutraceuticals in the Middle East market: Claim, pharmaceutical quality and safety assessments. Int J Pharmaceutics 492: 109-119, 2015.

In Press:

1. Khalil HA, El-Yazbi AF, Belal TS, Hamdy DA. High performance liquid chromatographic assay for the simultaneous determination of posaconazole and vincristine in rat plasma. Int J Anal Chem

Under preparation:

1. El-Sayed KS, El-Yazbi AF, El-Gowelli HM, El-Mas MM. Divergent effects for celecoxib and diclofenac on hemodynamic and left ventricular actions of cyclosporine in female rats. J Cardiovasc Pharmacol

2. Kandil NH, El-Sayed RM, Saad R, Carapinha J, EL-Yazbi AF. The Impact of pharmaceutical education and auditing regarding antibiotic use for surgical prophylaxis in Egyptian hospitals: A pharmacoeconomic study.

3. Invited review: El-Yazbi AF, Abd El-Rahman KS, Moreno-Dominguez A. Molecular mechanisms regulating the arterial myogenic response in health and disease: Novel insights. Biochem Pharmacol

Conference Papers:

1. Daniel EE, El-Yazbi AF, and Boddy G. Role of sequestered extracellular calcium in ICC pacing of intestine. Neurogastroenterol Motil 17: 611, 2006.

2. El-Yazbi AF, Cho WJ, and Daniel EE. Caveolin-1 knock-out

affects NANC inhibitory mediators differently in circular vs. longitudinal muscle layers of the mouse small intestine. Neurogastroenterol Motil 17: 611, 2006.

3. El-Yazbi AF, Boddy G, Schulz R, and Daniel EE. Differential

response to nitric oxide donors in circular vs. longitudinal muscles of wild type and caveolin-1 knock out mouse small intestine. Neurogastroenterol Motil 17: 611, 2006.

4. Omar AG, Sharabi FM, Daabees TT, El-Mallah AI, and El-Yazbi AF. Comparative functional antagonistic potencies of tamsulosin and terazosin at alpha1-adrenoceptors in vitro. 47th Annual Conference of the Egyptian Society of Pharmacology and Experimental Therapeutics, Helwan, Egpyt, September 2005.

5. El-Yazbi AF, Cho WJ, Schulz R and Daniel EE. Caveolin-1

knockout alters β-adrenoceptor function in mouse small intestine. FASEB J 20: A248, 2006.

6. Chow AK, Cena J, El-Yazbi AF, Holt A, Daniel EE, and Schulz

R. Caveolin-1 inhibits matrix metalloproteinase-2 activity in the heart. Canadian Cardiovascular Society Congress, Vancouver BC, October, 2006.

7. El-Yazbi AF, Sommer B, Bazan-Perkins B, Cho WJ, Montano

LM, and Daniel EE. H1- and 5-HT2A-receptor-mediated contraction of bovine tracheal smooth muscle requires intact caveolae and occurs through the activation of Rho-dependent Kinase. Pharmacology and Therapeutics Conference, Banff, March 2007.

8. El-Yazbi AF, Cho WJ, Cena J, Schulz R, Daniel EE. Smooth

muscle nNOS, co-localized with caveolin-1, modulates depolarization-induced contraction in mouse small intestine. FASEB J 21: A808, 2007.

9. El-Yazbi AF, Johnson RP, Takeya K, Walsh EJ, Walsh MP,

and Cole WC. Molecular evidence for the involvement of calcium sensitization in serotonin-induced cerebrovascular constriction. FASEB J 23:931.1, 2009.

10. Zhong X, Walsh E, El-Yazbi A, Cole W. Heteromultimeric

Kv2.1/Kv9.3 channels contribute to myogenic control of rat middle cerebral arterial (RMCA) diameter. FASEB J 24: 1033.8, 2010.

11. El-Yazbi AF. Possible involvement of cytoskeletal

reorganization in PKC-induced cerebroarterial constriction. FASEB J 24: 957.7, 2010.

12. El-Yazbi AF, Walsh EJ, Walsh MP, and Cole WC. Myogenic

constriction occurs in the absence of a detectable increase in pLC20 in the presence of agonist-induced tone. FASEB J 24: 956.1, 2010.

13. El-Yazbi AF, Johnson RP, Takeya K, Walsh EJ, Walsh MP,

and Cole WC. Rho kinase-dependant calcium sensitization in the interplay between pressure- and agonist-induced constriction of cerebral artery. Basic Clin Pharmacol Toxicol 107: Suppl 1 162-692, 2010.

14. El-Yazbi AF, Walsh E, Walsh M, and Cole W. Potential

involvement of actin cytoskeleton reorganization in generation of the arterial myogenic response. FASEB J 25: 1020.3, 2011.

15. Abdelalim LR, Soudan HM, El Zarka HA, Mohamed NK, El-

Yazbi AF, Hamdy DA. Bridging between pharmacy education and practice: Implementation and evaluation of Students’ patient counseling skills. Dubai International Pharmaceuticals and Technologies Conference, March 2014.

16. El-Yazbi AF. A calcium-independent PKC isoform mediates cerebral vasoconstriction through actin cytoskeleton reorganization. FASEB J 28: 841.2, 2014.

17. El-Sayed KS, El-Yazbi AF, El-Gowelli HM, El-Mas MM.

Divergent effects for celecoxib and diclofenac on hemodynamic and left ventricular actions of cyclosporine in female rats. FASEB J 29: 1025.11, 2015.

18. Khalil HA, El-Yazbi AF, Belal TS, Hamdy DA. Development of

a High Performance Liquid Chromatographic Assay for The Simultaneous Determination of Posaconazole and Vincristine in Rat Plasma and Its Application in a Drug Interaction Study. J Pharm Pharm Sci 18: 2015.

Presentations: 1. Caveolin-1 gene knockout impairs nitrergic function in mouse

small intestine. Pharmacology Research Day, University of Alberta, June 2nd 2005.

2. Alteration of myogenic and neural functions in mouse small

intestine by caveolin-1 knockout. Department of Pharmacology Seminars, University of Alberta, November 30th 2005.

3. Caveolin-1 knockout alters β-adrenoceptor function in mouse

small intestine. Pharmacology Research Day, University of Alberta, May 2nd 2006.

4. Caveolin-1 regulates MMP-2 activity in the heart. Department

of Pharmacology Seminars, University of Alberta, September 11th 2006.

5. Caveolin-1 knockout alters neural and myogenic function in mouse small intestine. Department of Pharmacology Seminars, University of Alberta, November 5th 2007.

6. Molecular evidence for the involvement of calcium sensitization

in serotonin-induced cerebrovascular constriction. ASPET Platform Session, EB2009, April 2009, New Orleans, LA.

7. Myogenic constriction occurs in the absence of a detectable

increase in pLC20 in the presence of agonist-induced tone. ASPET Young Investigator Session, EB2010, Annaheim, CA.

8. Weekly Medication Awareness Group at the Calgary Mental

Health Centre, CARNAT Centre. 9. Drugs associated with a risk of falls, Rehabilitation Medicine

Department, Peter Lougheed Centre, Calgary, Alberta, January 2012.

10. Establishing a foundation for patient education: Effective

approaches for communication of health information, September 2013, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

11. Aminoglycoside dosing: Concentration-dependent vs. time-

dependent: An audience-driven session, December, 2013, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

12. Rational Management of Pharmaceutical Care, December

2013, Alexandria Regional Centre for Women’s Health and Development, Alexandria, Egypt.

13. Vancomycin Therapeutic Drug Monitoring, January 2014,

Alexandria Pharmacist Syndicate, Alexandria, Egypt. 14. A case-based approach for primary prevention of

cardiovascular disorders, February 2014, Alexandria Pharmacist Syndicate, Alexandria, Egypt.

15. A case-based approach for management of atrial fibrillation,

February 2014, Alexandria Pharmacist Syndicate, Alexandria,

Egypt. 16. Appropriate selection of antibiotic therapy, bacterial sensitivity

and resistance mechanisms, February 2014, Health Affairs Directorate in Beheira, Damanhour, Beheira, Egypt.

17. Evidence-based approaches for handling of selected infectious

diseases, February 2014, Alexandria Regional Centre for Women’s Health and Development, Alexandria, Egypt.

18. Novel molecular mechanisms for the regulation of arterial

myogenic response, February 2014, Faculty of Pharmacy Graduate Student Research Day, Alexandria, Egypt.

19. Regulation and organization of the Pharmacy Profession in

North America, March 2014, Alexandria Pharmacists Syndicate, Alexandria, Egypt.

20. Education and Management of Diabetic Patients, April 2014,

Wadi El-Nil Hospital Pharma-Kampus Program, Cairo, Egypt. 21. Pharmacotherapeutic and lifestyle interventions for

management of type II diabetes, June 2014, Regional Centre for Women’s Health and Development, Alexandria, Egypt.

22. Education and Management of Diabetic Patients, June 2014,

Merck Sharpe & Dohme training session, Alexandria, Egypt. 23. Women’s health: Pre- and peri-natal concerns, August 2014,

Regional Centre for Women’s Health and Development, Alexandria, Egypt.

24. Women’s Health: Supportive measures in health emergencies,

August 2014, Regional Centre for Women’s Health and Development, Alexandria, Egypt.

25. A stepwise approach to management of diabetes, Takeda

training session, September 2014, Cairo, Egypt. 26. An introduction to OSCE: How to construct an Objective

Structured Clinical Examination, BAU Preceptor Training Program, September 2014, Beirut, Lebanon.

27. The nature of assessment: A quick guide to student evaluation,

BAU Faculty and Preceptor Training Program, September 2014, Beirut, Lebanon.

28. Diabetic patient education and self-management of diabetes,

the Order of Pharmacists in Lebanon, November 2014, Beirut, Lebanon.

29. Novel molecular mechanisms for the regulation of arterial

myogenic response, Faculty of Medicine, The American University of Beirut, December 2014, Beirut, Lebanon.

30. The evolution of pharmacy practice framework and the role of

pharmacists within healthcare systems, The Regional Centre for Women’s Health and Development, December 2014, Alexandria, Egypt.

31. Education and Management of Diabetics: Empowering patients

to be equal partners in healthcare, March 2015, Health Affairs Directorate in Beheira, Damanhour, Beheira, Egypt.

32. Education and Management of Diabetics: Empowering patients

to be equal partners in healthcare, April 2015, Take Off training Program in partnership with Takeda Pharmaceuticals, Agouza Police Hospital, Cairo, Egypt.

33. Invited presentation: Bugs vs. Drugs: Proper selection of

antibiotics in face of increasing antibiotic resistance. 23rd Order of Pharmacists of Lebanon Congress, Beirut, Lebanon, October 16, 2015.

34. Guest Lecture: Pregabalin: A pharmacological Profile, Pain

School Program, The Egyptian Society for Regional Anesthesia and Pain Management, January, 2016.

Awards:

1. The Ministry of Higher Education Award for Top University Students, Egypt, 1996-2001.

2. The University of Alexandria Award for Top Pharmacy

Student, Egypt, 2001.

3. The Department of Pharmacology Award for Excellence, University of Alberta, Canada, 2005.

4. The Provost Doctoral Entrance Award, University of Alberta,

Canada, 2005 ($8,000).

5. Izaak Walton Killam Memorial Scholarship, Killam Trusts,

Canada, 2006 ($32,000/year for 2 years; the most prestigious scholarship offered to a graduate student at the University of Alberta)

6. The Department of Pharmacology Award for Excellence,

University of Alberta, Canada, 2006.

7. The Alberta Heritage Foundation for Medical Research Studentship, Canada, 2007 ($20,000/year offered for 5 years and used for 1 year).

8. Andrew Stewart Graduate Memorial Prize, University of

Alberta, Canada, 2007 ($5,000; the highest level honour offered to a graduate student at the University of Alberta).

9. Best Paper Award, American Society of Pharmacology and

Experimental Therapeutics, EB2007, Washington DC, 2007 ($500).

10. The Alberta Heritage Foundation for Medical Research

Fellowship, Canada, 2008 ($35,000/year for 3 years).

11. Best Paper Award, American Society of Pharmacology and Experimental Therapeutics, EB2008, San Diego CA, 2008 ($500).

12. The Canadian Institutes for Health Research Fellowship,

Canada, 2008 ($40,000/year for 3 years).

13. The Heart and Stroke Foundation of Canada Research Fellowship, Canada, 2008 (offered and declined, $44,000/year for 3 years).

14. ASPET Post Doctoral Scientist Award, EB 2009, New

Orleans ($500).

15. ASPET Post Doctoral Scientist Award, EB 2010, Anaheim ($500).

16. ASPET Post Doctoral Scientist Award, EB 2011,

Washington DC ($500). Editorial and reviewing activities:

1. Independent Reviewer for: - The Journal of Pharmacology and Experimental

Therapeutics - The Journal of Diabetes and its Complications - Biochemical Pharmacology

D. Administrative Experience:

2013-2015: Executive Director, Quality Assurance Unit, Faculty of Pharmacy, Alexandria Universtiy.

The unit is mandated to continuously review and maintain the highest standards of academic and operational performance of the Faculty of Pharmacy and fulfill all the requirements for accreditation by the National Authority for Quality Assurance and Accreditation of Education.

2010-Present: I jointly own and co-founded ClinMedEx Inc. At ClinMedEx we specialize at offering world-class consultations and career advice to foreign-trained healthcare professionals aspiring to practice in Canada. As well, ClinMedEx is committed to the collaboration with Middle Eastern counterparts to provide knowledge and product transfer in the healthcare field. More information available at www.clinmedex.ca, www.facebook.com/groups/164575960253953/, and https://www.facebook.com/pages/ClinMedEx/182320105129103?ref=stream

2011-2013: I owned and managed the operations of the outpatient pharmacies at the Peter Lougheed Centre and the Foothills Medical Centre in Calgary, Canada. These are the two main adult hospitals in Southern Alberta. Combined, these two pharmacies are very complex $10 M operations. I performed the following during my tenure:

- I helped transition the business from the public sector to a privately owned healthcare enterprise working closely with government-funded institutions.

- I interviewed and hired the entire team of staff composed of pharmacists and technicians. I trained them up to the standards jointly identified with Alberta Health Services in the Standard Operation Procedures identified in the next point.

- I participated in designing a number of operational, financial, and human resource procedures and policies to fit the transition of the business model and ensure efficiency and stability.

- I was in charge of the only two sites providing pharmacy services to ambulatory patients of specialty adult clinics in southern Alberta and Eastern British Columbia. These clinics include: The Home Parenteral Therapy Clinic

(for antibiotics and pain management) , The Tom Baker Cancer Centre , The Hematology and Blood Cancers Clinic , Anticoagulation Management Services , Pulmonary Hypertension Clinic, and Congenital Heart Disease Clinic.

- I was in charge of the only two sites providing pharmaceutical services and dispensing of organ rejection prevention medications for all adult post-transplant patients in Southern Alberta and Eastern British Columbia.

- I was in charge of the manufacturing of sterile IV preparations including antibiotics and pain management medications for the entire population of adult ambulatory patients seen at Home Parenteral Therapy Program clinics in Southern Alberta.

- My two sites participated regularly in dispensing specialty, experimental, and restricted program medication including Special Access Program medications.

- One of my sites was in charge of maintaining therapy for two major mental health programs in Calgary: the CARNAT Centre Program aiming to rehabilitate schizophrenia patients and reintegrate them in society, and the Forensic Assessment Outpatient Service that oversees the continuity of treatment of convicted criminals who received pardons on psychiatric basis.

- I developed a close relationship with pharmaceutical companies to maintain helping patients in need for expensive medications through compassionate programs.

- All the previous functions were performed in addition to the regular pharmacy services provided to the general public and to patients discharged from these sites.

2004-2007: I managed the caveolin-1 knockout mice breeding colony at the University of Alberta: I organized and evaluated the numbers of breeding pairs, off-spring output, the number of housed animals, the number of animals produced for laboratory needs, and optimized the costs of animal breeding according to the research requirements.

2003-2004: I managed the pharmacy of El-Emary Charity Hospital in Alexandria, Egypt: I Organized the pharmacy business affairs and accounts, balanced the drugs in stock, over-looked bids for the hospital medical and pharmaceutical supplies, recruited and trained junior pharmacists, in addition to the basic pharmacy responsibilities of patient counseling, drug dispensing, and preparation compounding.

E. Advocacy and Lobbying Activities: I performed these activities by carrying out tasks through the following organizations:

2014: Represented the Faculty of Pharmacy, Alexandria University in the Pharmaceutical Education Sector Committee at the Supreme Council of Universities in Egypt to promote and defend the establishment of a First Professional PharmD degree to replace the traditional Bachelor’s degree offered by the Egyptian universities. The efforts led to initial acceptance in the context of establishing a council to oversee practical training of pharmacists and construct a system for examinations for entry-level certification and re-certification.

2013: The Alberta Pharmacists Association and Shoppers Drug Mart lobbying team: As a lead participant of the activities that aimed to lobby the politicians in the province of Alberta to review recently adopted policies in generic drug pricing and the compensation model for pharmacy services. As a result of continuous engagement with politicians and political conventions, the government decided to undergo the legislated change in a much longer transition period and to freeze any further reduction in the professional fees model. Moreover, the cuts in generic drug pricing were compensated by funds that were allocated to reimburse professional services such as medication reviews, injections, and comprehensive care plans.

2012: Shoppers Drug Mart Negotiating Team with the Health Sciences Association of Alberta (HSAA): HSAA was the labor union representing the personnel working at the outpatient pharmacies that I owned. We were able to negotiate a collective bargaining agreement that secured a sustainable business environment while addressing the needs of the staff. Innovative solutions were found to circumvent any potential legal or labor relations barriers.

2006: The Egyptian Students Association in North America: As a member of the Executive Committee and the President of this association, we were tasked with negotiating an increase in the salaries allocated by the Ministry of Higher Education in Egypt to Mission’s Students. Our efforts were successful in securing an increase in the salaries of these students.

2005: As a member of the executive team of the Edmonton Chapter of the Egyptian Students Association, I was able to participate in lobbying the administration of the University of Alberta to block a proposed hike in the differential tuition fees charged against international students at the University of Alberta. Following comprehensive efforts, there was no increase in the differential tuition fees.

All of the previous advocacy activities were held in a congenial manner. Efforts were aimed at presenting a strong information-substantiated case portraying the mutual goals and the potential benefits of collaboration towards them. There was not a single activity that I participated in that resulted in anarchy or job action (strikes or lock-outs).

F. Training and Mentorship Activities: 1. Offered support and mentorship to several post-graduate students at the University of Calgary, Calgary, Canada: - Connie Liao - Zoe Zhong - Rania El-Mufti - Khaled Abdel Rahman 2. Training of Pharmacy interns planning to challenge the Pharmacy Examining Board of Canada Qualifying Examinations: - More than 200 pharmacist interns who successfully challenged the examination as a part of the activities of ClinMedEx Inc. 3. Organization of several training and continuing education workshops for pharmacy students and clinical pharmacists in the fields of therapeutics and patient education in collaboration with the Ministry of Health in Egypt, the Pharmacists syndicate in Alexandria, and the Order of Pharmacists in Lebanon.

4. Supervision of Post-graduate students at the Faculty of Pharmacy, Alexandria University:

- Karim Samy, Master of Pharmaceutical Sciences (Pharmacology)

- Ghada Haddad, Master of Pharmaceutical Sciences (Pharmaceutics)

- Mohamed Abdel Wahed, Master of Pharmaceutical Sciences (Pharmacology)

- Hadeel Adel Khalil, Master of Pharmaceutical Sciences (Analytical Chemistry)

5. Initiated and participated in the organization of the Pharmacy Graduate Student Research Day in the Faculty of Pharmacy, Alexandria University, February 2014, Alexandria, Egypt.

6. Academic Supervisor of the Alexandria Scientific Pharmaceutical Students Association (ASPSA), December 2013-present. 7. Graduate Studies Coordinator, Department of Pharmacology and Toxicology, Faculty of Pharmacy, Alexandria University, August 2013-present. 8. Designed and supervised the Hospital Summer Training Program for Fourth Year Clinical Pharmacy Program students at Alexandria University, Summer 2014. 9. Provided training sessions and designed a training program for Pharmacy students preceptors participating in the Pharmacy Practice Experiential learning program at Beirut Arab University, Beirut, Lebanon, Fall 2014.

G. Consultation, curricular and course development activities: 1. Reviewed the Patient-Oriented Problem Solving Systems in Pharmacology Exercises based on an invitation by the Division of Pharmacology Education of the American Society of Pharmacology and Experimental Therapeutics. 2. Developed the framework for “The comprehensive patient care diploma” at the Faculty of Pharmacy, Alexandria University. This is a graduate level diploma intended to offer specialized knowledge and training to ambulatory care pharmacists dealing with outpatients and community-treated patients. 3. Assisted in the design and organization of the course content and examination setup of medical courses for fifth year clinical pharmacy students at the Faculty of Pharmacy at Alexandria University. 4. Designed and validated the Fourth Year Experiential Learning Course at the Faculty of Pharmacy in Alexandria Unibversity involving developing patient care competencies within a hospital practice setting. 5. Provided continuous academic and clinical support to Stellar, a private pharmacist training firm in Cairo, Egypt, 2013-2014. 6. Provided continuous pharmacist training support to the Regional Centre for Women’s Health and Development, Alexandria, Egypt, 2013-2014.

7. Provided consultation to Andalusia hospital groups in terms of standard operational procedures development and operational flow to meet the requirements of the Joint Commission International, March-June 2014. 8. Developed and designed Pharmacy Practice Experience 4, a fourth level summer training course for undergraduate students at the Faculty of Pharmacy in Beirut Arab University. 9. Participated in the design and delivery of the curriculum for the preceptor training program at Beirut Arab University, September-November 2014. 10. Provided consultation to the Faculty of Pharmacy in Beirut Arab University regarding curricular modification to meet the requirements for provisional accreditation by the Canadian Council for Accreditation of Pharmacy Programs (CCAPP), Fall 2014. (CCAPP provisional accreditation obtained in June 2015) 11. Designed a training program for faculty members and preceptors at the Faculty of Pharmacy in Beirut Arab University to establish an Objective Structure Clinical Examination as a means of evaluation for the Experiential Program Courses, September 2014. 12. Designed a framework for measurement and reporting of Key Performance Indicators at the Faculty of Pharmacy at Beirut Arab University, October 2014. 13. Chaired a committee for reorganization and development of the course map for the Pharmacy Practice Department at the Faculty of Pharmacy at Beirut Arab University, November 2014. 14. I sit on the executive committee overseeing the PharmD program at the Faculty of Pharmacy in Beirut Arab University, November 2014. 15. I sit on the committee developing the promotion and appointment criteria for the clinical faculty members at the Faculty of Pharmacy in Beirut Arab University, November 2014. 16. I am a member of the Evaluation and Assessment Committee of the Advanced Pharmaceutical Education Forum in the Middle East, March 2015.

17. Provided consultation to the Arab Academy for Science and Technology regarding establishing an undergraduate Pharmacy program that satisfies Canadian educational standards and accreditable by CCAPP. 18. Provide pharmacoeconomic consultations as a part of the activities of Carapinha & Company, a Boston-based market access studies firm. 19. I sit on the Committee for International Relations, Alexandria University, July 2015.

H. Research and Operational Grants: Co-Principal Investigator on each of the following projects:

1. Establishing a cell culture laboratory in the Medical Campus in Alexandria University (ALEX-REP/AURF, L.E. 500,000, 2014) 2. Heme oxygenase modulation of cardiovascular derangements evoked by the combined cyclosporine/NSAIDs regimen in rats: Functional, structural, and molecular studies (ALEX-REP/AURF, L.E. 156,000, 2014) 3. Effect of hyperlipidemia on posaconazole-vincristine drug-drug interaction in rat. (STDF-Egypt, LE 750,000, 2014)

I. Volunteer Activities:

2005-2007: Fund-raising for the Canadian Cancer Society: I participated in the annual door-to-door campaign to collect money for the Canadian Cancer Society. July 2004 – November 2007: I actively participated in the activities of the Edmonton chapter of the Egyptian Student Association (ESA) of North America. I was the Vice-President of the ESA May 2005-October 2005, President October 2005-May 2006, and Treasurer May 2006-May 2007. The main goals of the ESA are to help Egyptian students on campus in various aspects. We also promote interest in Egyptian culture on campus by organizing a semi-annual Egypt Day in the beginning of the fall and winter semesters. More information about our activities and events can be seen at www.ualberta.ca/~esa106. January 2006-May 2007: I participated actively in the activities of the Egyptian Students Association in North America (ESANA). I have been the

Coordination Officer of the ESANA January 2006- January 2007 and President January 2007-June 2007. ESANA currently operates several projects that mainly aim to address the needs of Egyptian graduate students in North America in addition to promoting the interest of Egyptian youth to pursue graduate studies in Canada and USA. For more details visit our website at www.esana.org. March 2007: I helped in the organization of the Pharmacology and Therapeutics Conference, the Annual conference of the Western Pharmacology Society and the Canadian Pharmacological Society in Banff, Alberta, Canada. August 2007 – April 2010: I sat on the Executive Committee of the Division of Systems and Integrative Pharmacology of the American Society of Pharmacology and Experimental Therapeutics as a the Young Scientist Committee Chairperson.

October 2011-May 2013: I ran a weekly medical information session for the Calgary Mental Health Centre patients. These sessions provide the patients with useful information regarding general health issues and answer any medical questions they might have. May 2013: I completed the 10 Kilometre Sportcheck Mothers’ Day Run in Calgary, Alberta.

J. Memberships:

Member of the General Syndicate of Pharmacists, Egypt

Member of the American Society of Pharmacology and Experimental Therapeutics (ASPET)

Member of the Canadian Pharmacological Society (CPS)

Invited member of the American Association for the Advancement of Sciences (AAAS)

Member of the Alberta College of Pharmacists, Alberta, Canada

Certified member of the Board of Pharmacy Specialties, Washington DC, USA

K. Contact Information: e-mail: elyazbi@yahoo.com

Daytime phone: +20 3 483 1351

Cell phone: +20 11 5588 1772

Home phone: +20 3 428 8228